Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis - PubMed
Review
Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis
Beppe Micallef-Trigona. Depress Res Treat. 2014.
Abstract
Electroconvulsive therapy (ECT) is the longest standing psychiatric treatment available and has unequivocal benefit in severe depression. However this treatment comes with a number of side effects such as memory impairment. On the other hand, Repetitive Transcranial Magnetic Stimulation (rTMS) is a relatively new form of treatment which has been shown to be efficacious in patients suffering from a number of psychopathologies, including severe depression, with few reported side effects. Due to its potential therapeutic efficacy and lack of side effects, rTMS has gained traction in the treatment of depression, with a number of authors keen to see it take over from ECT. However, it is not clear whether rTMS represents a therapeutic alternative to ECT. This meta-analysis will therefore compare the "gold standard" treatment for severe depression, with the relatively new but promising rTMS. A literature search will be performed with the intention to include all randomised clinical trials. The null hypothesis is that there is no difference in the antidepressant efficacy between the two types of treatment modalities. Statistical analysis of Hamilton Depression Rating Scale (HDRS) scores will be performed.
Figures
Similar articles
-
McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M. McLoughlin DM, et al. Health Technol Assess. 2007 Jul;11(24):1-54. doi: 10.3310/hta11240. Health Technol Assess. 2007. PMID: 17580003 Clinical Trial.
-
Ren J, Li H, Palaniyappan L, Liu H, Wang J, Li C, Rossini PM. Ren J, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:181-9. doi: 10.1016/j.pnpbp.2014.02.004. Epub 2014 Feb 18. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24556538 Review.
-
Health Quality Ontario. Health Quality Ontario. Ont Health Technol Assess Ser. 2016 Mar 1;16(5):1-66. eCollection 2016. Ont Health Technol Assess Ser. 2016. PMID: 27099642 Free PMC article. Review.
-
Hansen PE, Ravnkilde B, Videbech P, Clemmensen K, Sturlason R, Reiner M, Parner E, Rosenberg R, Vestergaard P. Hansen PE, et al. J ECT. 2011 Mar;27(1):26-32. doi: 10.1097/YCT.0b013e3181d77645. J ECT. 2011. PMID: 20351570 Clinical Trial.
-
Xie J, Chen J, Wei Q. Xie J, et al. Neurol Res. 2013 Dec;35(10):1084-91. doi: 10.1179/1743132813Y.0000000245. Epub 2013 Jul 25. Neurol Res. 2013. PMID: 23889926
Cited by
-
Transcranial magnetic stimulation for the treatment of major depression.
Janicak PG, Dokucu ME. Janicak PG, et al. Neuropsychiatr Dis Treat. 2015 Jun 26;11:1549-60. doi: 10.2147/NDT.S67477. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26170668 Free PMC article. Review.
-
Epigenome Defines Aberrant Brain Laterality in Major Mental Illnesses.
Abdolmaleky HM, Nohesara S, Thiagalingam S. Abdolmaleky HM, et al. Brain Sci. 2024 Mar 7;14(3):261. doi: 10.3390/brainsci14030261. Brain Sci. 2024. PMID: 38539649 Free PMC article. Review.
-
Fitzgibbon KP, Plett D, Chan BCF, Hancock-Howard R, Coyte PC, Blumberger DM. Fitzgibbon KP, et al. Can J Psychiatry. 2020 Mar;65(3):164-173. doi: 10.1177/0706743719890167. Epub 2019 Dec 5. Can J Psychiatry. 2020. PMID: 31801363 Free PMC article.
-
Depression and Its Phytopharmacotherapy-A Narrative Review.
Dobrek L, Głowacka K. Dobrek L, et al. Int J Mol Sci. 2023 Mar 1;24(5):4772. doi: 10.3390/ijms24054772. Int J Mol Sci. 2023. PMID: 36902200 Free PMC article. Review.
-
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.
Papakostas GI, Ionescu DF. Papakostas GI, et al. Mol Psychiatry. 2015 Oct;20(10):1142-50. doi: 10.1038/mp.2015.92. Epub 2015 Jul 7. Mol Psychiatry. 2015. PMID: 26148812 Review.
References
-
- Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. The Journal of ECT. 2004;20(1):13–20. - PubMed
-
- Geddes J, Carney S, Cowen P, et al. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. The Lancet. 2003;361(9360):799–808. - PubMed
-
- Husain MM, Rush AJ, Fink M, et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ECT (CORE) report. Journal of Clinical Psychiatry. 2004;65(4):485–491. - PubMed
-
- Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. The Journal of ECT. 2001;17(4):244–253. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources